The medical community, led by Dr. Eytan Hyam, has recognized cannabis as a highly effective treatment for individuals suffering from PTSD, with the unique Syqe inhaler offering a solution to the challenge of dosing accuracy. This innovative medical marijuana inhaler, loaded with capsules to prevent overconsumption, ensures that patients receive the prescribed amount of cannabis without risking side effects associated with inconsistent dosages.
Syqe Medical's SyqeAir Inhaler has gained regulatory approvals and validation through clinical trials, providing patients with a reliable and clinically proven method of managing their medical cannabis treatment. By addressing concerns about dosing precision and side effects, the inhaler offers a safer and more efficient alternative to traditional methods of consuming medical marijuana, such as smoking. Additionally, the agreement between Syqe Medical and the Israeli Ministry of Defense highlights the growing recognition of the inhaler's effectiveness in providing veterans with a controlled and effective means of accessing medical cannabis treatment.